A Study on clinical patterns of mucocutaneous candidiasis in immunosuppressed patients

• Main Author: Subhashini Mohan (Author)
• Format: Book
• Published: International Journal of Dermatology and Clinical Research - Peertechz Publications, 2017-12-12.
• Subjects: Research Article
• Online Access: Connect to this object online.

<p><strong>Background: </strong>Candidasis is the most common superfi cial fungal infection in immunocompromised patients. With the advent of wide spectrum of immunosuppressive drug and increase in HIV patients, there is a change in the epidemiology and clinical presentation of mucocutaneous candidiasis.</p><p><strong>Aim and Objective: </strong>This study has been designed to study epidemiology and the common clinical patterns of mucocutaneous candidiasis in immunosuppressed patients.</p><p><strong>Materials and methods: </strong>A cross sectional study on epidemiology and clinical patterns of mucocutaneous candidiasis among 100 immunosuppressed patients of all age groups attending Dermatology OPD in a tertiary care center.</p><p><strong>Results: </strong>Maximum number of patients were in third and fourth decade. Females were more frequently (73%) affected than males (27%). Type 2 diabetes was the most common cause of immunosuppression followed by steroid intake (20%), cancer patients (10%) and HIV (5%). Oral candidiasis was the frequently observed clinical pattern (48%) followed by vulvovaginal candidiasis (45%), intertriginous lesions on the fingers (2%), toes (2%), and neck (1%). Balanoposthitis was observed in 2% of patients.</p><p><strong>Limitation:</strong> small sample size.</p><p><strong>Conclusion: </strong>Diabetes was the common cause of immunosuppression. Oral candidiasis was the common clinical pattern observed among them.</p>